• 1. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

Comprehensive Overview of 1-(2,3-dihydro-1H-inden-1-yl)cyclobutylmethanamine (CAS No. 2229031-70-1)

1-(2,3-dihydro-1H-inden-1-yl)cyclobutylmethanamine (CAS No. 2229031-70-1) is a structurally unique organic compound that has garnered significant attention in pharmaceutical and chemical research. This molecule features a cyclobutylmethanamine core linked to a 2,3-dihydro-1H-indene moiety, a combination that offers intriguing possibilities for drug discovery and material science applications. Researchers are particularly interested in its potential as a building block for novel therapeutics, given its balanced lipophilicity and molecular rigidity.

The compound’s indenyl and cyclobutyl groups contribute to its distinct physicochemical properties, including solubility and stability under various conditions. Recent studies highlight its relevance in targeting central nervous system (CNS) disorders, a hot topic in 2024 due to rising global interest in neurodegenerative diseases and mental health. Its structural motifs align with trends in fragment-based drug design (FBDD), a method increasingly adopted by AI-driven platforms to accelerate drug development.

From an industrial perspective, 1-(2,3-dihydro-1H-inden-1-yl)cyclobutylmethanamine is explored for its role in high-performance polymers and catalysts. The indenyl group’s aromaticity and the cyclobutyl ring’s strain energy make it a candidate for advanced materials. Sustainability-focused research also investigates its potential in green chemistry, aligning with the demand for eco-friendly synthetic routes.

Analytical challenges, such as chiral separation and stereochemical stability, are frequently discussed in forums and publications. These aspects are critical for ensuring reproducibility in pharmaceutical applications. The compound’s CAS No. 2229031-70-1 serves as a key identifier in patent literature, reflecting its commercial viability.

In summary, 1-(2,3-dihydro-1H-inden-1-yl)cyclobutylmethanamine exemplifies innovation at the intersection of medicinal chemistry and material science. Its versatility and relevance to cutting-edge research ensure its prominence in scientific discourse.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)